(Q36637669)

15 August 2017

1 reference

title

Clinical trials of PUFAs in depression: State of the art. (English)

1 reference

15 August 2017

1

Yamima Osher

1 reference

15 August 2017

2

Robert H Belmaker

1 reference

15 August 2017

Boris Nemets

3

1 reference

15 August 2017

publication date

1 January 2006

1 reference

World Journal of Biological Psychiatry

15 August 2017

published in

1 reference

15 August 2017

volume

7

1 reference

15 August 2017

issue

4

1 reference

15 August 2017

page(s)

223-230

1 reference

Fish oil prevents the adrenal activation elicited by mental stress in healthy men.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F15622970600960173

Cognitive and physiological effects of Omega-3 polyunsaturated fatty acid supplementation in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600960173

Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600960173

Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600960173

Fish consumption and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600960173

A replication study of violent and nonviolent subjects: cerebrospinal fluid metabolites of serotonin and dopamine are predicted by plasma essential fatty acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600960173

Omega-3 fatty acid treatment and T(2) whole brain relaxation times in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600960173

Phospholipid metabolism and depression: the possible roles of phospholipase A2 and coenzyme A-independent transacylase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600960173

Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600960173

Optimal diets for prevention of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600960173

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600960173

The role of omega-3 fatty acids in the secondary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600960173

Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600960173

Omega-3 fatty acids for the prevention of postpartum depression: negative data from a preliminary, open-label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600960173

Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600960173

Omega-3 treatment of childhood depression: a controlled, double-blind pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600960173

Omega-3 Eicosapentaenoic Acid in Bipolar Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600960173

Omega-3 fatty acids and mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600960173

A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600960173

An overview of recent findings of the Stanley Foundation Bipolar Network (Part I).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600960173

Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600960173

Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600960173

Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600960173

The role of omega-3 fatty acids in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600960173

Do essential fatty acids have a role in the treatment of depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600960173

omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600960173

10.1080/15622970600960173

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference